Bimodal effect of lithium plasma levels on hippocampal glutamate concentrations in bipolar II depression: A pilot study

International Journal of Neuropsychopharmacology

Volumn 18, Issue 6, 2015, Pages 1-9

  Zanetti, Marcus V ^a   Otaduy, Maria C ^a   De Sousa, Rafael T ^a   Gattaz, Wagner F ^a   Busatto, Geraldo F ^a   Leite, Claudia C ^a   Machado Vieira, Rodrigo ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Bipolar disorder; Depression; Glutamate; Hippocampus; Lithium; Magnetic resonance spectroscopy

Indexed keywords

CHOLINE; CREATINE; GLUTAMIC ACID; INOSITOL; LITHIUM; N ACETYLASPARTIC ACID; WATER; LITHIUM DERIVATIVE; TRANQUILIZER;

ADULT; ARTICLE; BIPOLAR II DISORDER; BRAIN SIZE; CHRONOTHERAPY; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATIONAL STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HIPPOCAMPUS; HUMAN; LITHIUM BLOOD LEVEL; MALE; MENTAL PATIENT; METABOLITE; MONOTHERAPY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PILOT STUDY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOPHARMACOTHERAPY; TREATMENT DURATION; VOXEL BASED MORPHOMETRY; ADOLESCENT; AFFECT; BIPOLAR DISORDER; BLOOD; BRAZIL; DRUG EFFECTS; DRUG MONITORING; METABOLISM; PSYCHOLOGY; TIME FACTOR; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AFFECT; ANTIMANIC AGENTS; BIPOLAR DISORDER; BRAZIL; DRUG MONITORING; FEMALE; GLUTAMIC ACID; HIPPOCAMPUS; HUMANS; LITHIUM COMPOUNDS; MALE; PILOT PROJECTS; PROTON MAGNETIC RESONANCE SPECTROSCOPY; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84939199013     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyu058     Document Type: Article

References (42)

1. Amsterdam JD, Shults J. (2008) Comparison of short-term ven-lafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study. J Clin Psychopharmacol 28:171-181.
2. Beneyto M, Kristiansen LV, Oni-Orisan A, McCullumsmith RE, Meador-Woodruff JH (2007) Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Neuropsychopharmacology 32:1888-1902.
3. Bustillo JR (2013) Use of proton magnetic resonance spectros-copy in the treatment of psychiatric disorders: a critical update. Dialogues Clin Neurosci 15:329-337.
4. Capizzano AA, Jorge RE, Acion LC, Robinson RG (2007) In vivo proton magnetic resonance spectroscopy in patients with mood disorders: a technically oriented review. J Magn Reson Imaging 26:1378-1389.
5. Colla M, Schubert F, Bubner M, Heidenreich JO, Bajbouj M, Seifert F, Luborzewski A, Heuser I, Kronenberg G (2009) Glutamate as a spectroscopic marker of hippocampal structural plasticity is elevated in long-term euthymic bipolar patients on chronic lithium therapy and correlates inversely with diurnal corti-sol. Mol Psychiatry 14:696-704.
6. Dager SR, Corrigan NM, Richards TL, Posse S (2008) Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders. Top Magn Reson Imaging 19:81-96.
7. Du J, Wei Y, Liu L, Wang Y, Khairova R, Blumenthal R, Tragon T, Hunsberger JG, Machado-Vieira R, Drevets W, Wang YT, Manji HK (2010) A kinesin signaling complex mediates the ability of GSK-3beta to affect mood-associated behaviors. Proc Natl Acad Sci USA 107:11573-11578.
8. Ende G, Braus DF, Walter S, Weber-Fahr W, Henn FA (2000) The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study. Arch Gen Psychiatry 57:937-943.
9. First MB, Spitzer RL, Gibbon M, Williams JBW (1995) Structured clinical interview for DSM-IV axis I disorders, patient edition (SCID-I/P). New York: Biometrics Research, New York State Psychiatry Institute.
10. Frye MA, Watzl J, Banakar S, O'Neill J, Mintz J, Davanzo P, Fischer J, Chirichigno JW, Ventura J, Elman S, Tsuang J, Walot I, Thomas MA (2007) Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression. Neuropsy-chopharmacology 32:2490-2499.
11. Gasparovic C, Song T, Devier D, Bockholt HJ, Caprihan A, Mul-lins PG, Posse S, Jung RE, and Morrison LA (2006) Use of tissue water as a concentration reference for proton spectroscopic imaging. Magn Reson Med 55:1219-1226.
12. Gigante AD, Bond DJ, Lafer B, Lam RW, Young LT, Yatham LN (2012) Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis. Bipolar Disord 14:478-487.
13. Gigante AD, Lafer B, Yatham LN (2014) (1)H-MRS of hippocampus in patients after frst manic episode. World J Biol Psychiatry 15:145-154.
14. Guy W (1976) The clinical global impression scale. In: ECDEU assessment manual for psychopharmacology-revised, pp 218-222. Rockville, MD: US Dept. of Health, Education and Welfare, ADAMHA, MIMH Psychopharmacology Research Branch.
15. Hamilton M (1960) Rating scale for depression. J Neurol Neuro-surg Psychiatry 23:56-62.
16. Hochberg Y (1988) A sharper Bonferroni procedure for multiple tests of signifcance. Biometrika 75:800-802.
17. Howells FM, Ives-Deliperi VL, Horn NR, Stein DJ (2013) Increased thalamic phospholipid concentration evident in bipolar I disorder. Prog Neuropsychopharmacol Biol Psychiatry 41:1-5.
18. Khairova R, Pawar R, Salvadore G, Juruena MF, de Sousa RT, Soeiro-de-Souza MG, Salvador M, Zarate CA, Gattaz WF, Machado-Vieira R (2012) Effects of lithium on oxidative stress parameters in healthy subjects. Mol Med Rep 5:680-682.
19. Kleindienst N, Severus WE, Möller HJ, Greil W (2005) Is polarity of recurrence related to serum lithium level in patients with bipolar disorder? Eur Arch Psychiatry Clin Neurosci 255:72-74.
20. Konradi C, Zimmerman EI, Yang CK, Lohmann KM, Gresch P, Panta-zopoulos H, Berretta S, Heckers S (2011) Hippocampal interneu-rons in bipolar disorder. Arch Gen Psychiatry 68:340-350.
21. Kraguljac NV, Reid M, White D, Jones R, den Hollander J, Low-man D, Lahti AC (2012) Neurometabolites in schizophrenia and bipolar disorder-a systematic review and meta-analysis. Psychiatry Res 203:111-125.
22. Machado-Vieira R, Manji HK, Zarate CA Jr (2009) The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord 11(Suppl 2):92-109.
23. Machado-Vieira R, Ibrahim L, Henter ID, Zarate CA Jr (2012) Novel glutamatergic agents for major depressive disorder and bipolar disorder. Pharmacol Biochem Behav 100:678-687.
24. Machado-Vieira R, Soeiro-De-Souza MG, Richards EM, Teixeira AL, Zarate CA Jr (2014) Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approach. World J Biol Psychiatry 15:84-95.
25. Machado-Vieira R, Zanetti MV, de Sousa RT, Soeiro-de-Souza MG, Moreno RA, Busatto GF, Gattaz WF (2014) Lithium effcacy in bipolar depression with fexible dosing: a six-week, open-label, proof-of-concept study. Exp Ther Med 8:1205-1208.
26. McCullumsmith RE, Kristiansen LV, Beneyto M, Scarr E, Dean B, Meador-Woodruff JH (2007) Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder. Brain Res 1127:108-118.
27. Phillips ML, Ladouceur CD, Drevets WC (2008) A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelop-ment of bipolar disorder. Mol Psychiatry 13:829, 833-857.
28. Phillips ML, Swartz HA (2014) A Critical Appraisal of Neuroimag-ing Studies of Bipolar Disorder: Toward a New Conceptualization of Underlying Neural Circuitry and a Road Map for Future Research. Am J Psych 171:829-843.
29. Posse S, Otazo R, Caprihan A, Bustillo J, Chen H, Henry P-G, Mar-janska M, Gasparovic C, Zuo C, Magnotta V, Mueller B, Mullins P, Renshaw P, Ugurbil K, Lim KO, and Alger JR (2007) Proton Echo-Planar Spectroscopic Imaging of J-Coupled Resonances in Human Brain at 3 and 4 Tesla. Magn Reson Med 58:236-244.
30. Provencher SW (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30(6):672-679.
31. Quiroz JA, Gray NA, Kato T, Manji HK (2008) Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 33:2551-2565.
32. Rybakowski JK, Twardowska K (1999) The dexamethasone/corti-cotropin-releasing hormone test in depression in bipolar and unipolar affective illness. J Psychiatr Res 33:363-370.
33. Senaratne R, Milne AM, MacQueen GM, Hall GB (2009) Increased choline-containing compounds in the orbitofrontal cortex and hippocampus in euthymic patients with bipolar disorder: a proton magnetic resonance spectroscopy study. Psychiatry Res 172:205-209.
34. Soeiro-de-Souza MG, Dias VV, Figueira ML, Forlenza OV, Gattaz WF, Zarate CA Jr, Machado-Vieira R (2012) Translating neu-rotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder. Acta Psychiatr Scand 126:332-341.
35. Suppes T, Marangell LB, Bernstein IH, Kelly DI, Fischer EG, Zboyan HA, Snow DE, Martinez M, Al Jurdi R, Shivakumar G, Sureddi S, Gonzalez R (2008) A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression. J Affect Disord 111:334-343.
36. Teicher MH, Anderson CM, Polcari A (2012) Childhood maltreatment is associated with reduced volume in the hippocampal subfields CA3, dentate gyrus, and subiculum. Proc Natl Acad Sci USA 109:E563-572.
37. Wansapura JP, Holland SK, Dunn RS, Ball Jr WS (1999) NMR relaxation times in the human brain at 3.0 Tesla. J Magn Reson Imaging 9:531-538.
38. Watson S, Gallagher P, Ritchie JC, Ferrier IN, Young AH (2004) Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. Br J Psychiatry 184:496-502.
39. Young AH, McElroy SL, Bauer M, Philips N, Chang W, Olausson B, Paulsson B, Brecher M (2010) A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). J Clin Psychiatry 71:150-162.
40. Young RC, Biggs JT, Ziegler VE, Meyer DA (1978) A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429-435.
41. Yüksel C, Öngür D (2010) Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders. Biol Psychiatry 68:785-794.
42. Zhang Y, Brady M, Smith S (2001) Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imag 20:45-57.